{"disease":{"id":"stevens-johnson-syndrome","name":"Stevens-Johnson syndrome","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"prednisone","indication_name":"Severe erythema multiforme (Stevens-Johnson syndrome)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Severe erythema multiforme (Stevens-Johnson Syndrome)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"corticotropin","indication_name":"Stevens-Johnson syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Acthar Gel","generic_name":"CORTICOTROPIN","company_name":"Mallinckrodt Ireland","drug_phase":"marketed","molecular_target":"Melanocyte-stimulating hormone receptor","drug_class":"Adrenocorticotropic Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"prednisolone","indication_name":"Stevens-Johnson syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Stevens-Johnson syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03046914","title":"HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03659227","title":"Drug Reactions Sampling (COLLECTIONTOXIDERMIES)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06263140","title":"Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Chulalongkorn University","has_results":false},{"nct_id":"NCT05284929","title":"Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Sechenov University","has_results":false},{"nct_id":"NCT05320653","title":"Nutritional and Metabolic Management of Toxidermia Patients Requiring Intensive Care (TEN Metabolism)","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT05145959","title":"Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT04313725","title":"Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease","phase":"NA","overall_status":"TERMINATED","enrollment_count":28,"lead_sponsor_name":"Tangible Science","has_results":false},{"nct_id":"NCT05520086","title":"Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","has_results":false},{"nct_id":"NCT06474078","title":"Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":true},{"nct_id":"NCT07014059","title":"Autologous Serum Obtained by a Closed-Circuit Collection Device","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":16,"lead_sponsor_name":"GIANCARLO FATOBENE","has_results":false},{"nct_id":"NCT06926478","title":"Subconjunctival Humira for Boston Keratoprosthesis","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":8,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT02987257","title":"NATIENS: Optimal Management and Mechanisms of SJS/TEN","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT03585946","title":"Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}